ID   LASCPC-01
AC   CVCL_UE17
DR   ATCC; CRL-3356
DR   cancercelllines; CVCL_UE17
DR   GEO; GSM2050760
DR   Progenetix; CVCL_UE17
DR   Wikidata; Q95981291
RX   PubMed=27050099;
CC   Population: Caucasian.
CC   Doubling time: ~18 hours (PubMed=27050099); ~24 hours (ATCC=CRL-3356).
CC   Omics: SNP array analysis.
ST   Source(s): ATCC=CRL-3356
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C39903; Prostate adenocarcinoma with neuroendocrine differentiation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-80Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 02-05-24; Version: 6
//
RX   PubMed=27050099; DOI=10.1016/j.ccell.2016.03.001; PMCID=PMC4829466;
RA   Lee J.K., Phillips J.W., Smith B.A., Park J.W., Stoyanova T.,
RA   McCaffrey E.F., Baertsch R., Sokolov A., Meyerowitz J.G., Mathis C.,
RA   Cheng D.-H., Stuart J.M., Shokat K.M., Gustafson W.C., Huang J.-T.,
RA   Witte O.N.;
RT   "N-Myc drives neuroendocrine prostate cancer initiated from human
RT   prostate epithelial cells.";
RL   Cancer Cell 29:536-547(2016).
//